FDA to investigate concerns about coagulated milk

The Food and Drugs Authority (FDA) says it has taken steps to address consumer complaints about Nestle Ghana Limited’s coagulated milk products.

The authority stated that it had received consumer complaints and had recommended that Nestle respond to the allegations and launch a recall of impacted batches in accordance with best regulatory practices.
Mrs Delese Darko, the Authority’s Chief Executive Officer (CEO), described some extensive regulatory action taken yesterday and communicated to the Ghanaian Times in Accra, in a statement signed and issued yesterday and copied to the Ghanaian Times in Accra.

She said a complete Good Manufacturing Practice (GMP) inspection of Nestle’s manufacturing facility at Tema to establish the root cause of the coagulation of the evaporated milk had been done.

Mrs Darko also stated that a review of analytical reports, documentation of raw and packaging materials, and product analyses had been done.

The FDA CEO again said “a microbial analysis was conducted on samples taken from the manufacturing facility and complaint samples at the FDA Laboratory. Results from the analysis indicated that there was no microbial contamination of samples and therefore there is no food safety issue with the said coagulated milk products from Nestle.”

She said that analysis confirmed that there was no leaching of dangerous chemicals from the inner (lacquer) lining into the milk product.

Mrs Darko, therefore, noted that the root cause analysis done indicated that the skimmed milk powder (raw material) used to produce the milk complained of has poor heat stability.

“This results in them denaturing of the protein leading to the coagulation of the milk. Denatured protein however poses no health risk,” she added.